All ProductsDisplaying Products by Catalog Number (4600 - 4699)
01000200030004000500060007000800090010001100120013001400150016001700180019002000210022002300240025002600270028002900300031003200330034003500360037003800390040004100420043004400450046004700480049005000510052005300540055005600570058005900600061006200630064006500660067006800690070007100720073007400750076007700780079008000
| Cat. No. | Product Name / Activity |
|---|---|
| 4601 | TUG 891 |
| Potent and selective FFA4 (GPR120) agonist | |
| 4602 | LDN 27219 |
| Transglutaminase 2 (TG2) inhibitor; reversible | |
| 4603 | LUF 5834 |
| Potent adenosine A2A and A2B receptor partial agonist | |
| 4606 | CYM 9484 |
| Potent NPY Y2 receptor antagonist | |
| 4607 | LM 22A4 |
| Potent TrkB agonist | |
| 4609 | BMS 303141 |
| ATP citrate lyase inhibitor; orally bioavailable | |
| 4611 | PBP 10 |
| Selective FPR2 antagonist; cell permeable | |
| 4612 | URB 597 |
| Potent and selective FAAH inhibitor | |
| 4616 | Olmesartan |
| Potent AT1 antagonist | |
| 4617 | Penitrem A |
| Potent and selective KCa1.1 (BK) channel blocker | |
| 4618 | GW 6471 |
| PPARα antagonist | |
| 4619 | Melphalan |
| DNA alkylating agent; cytotoxic and antineoplastic | |
| 4621 | MKT 077 |
| Binds mot-2; selectively cytotoxic in cancer cells | |
| 4622 | MK 1903 |
| Potent and selective GPR109A (HCA2) agonist | |
| 4624 | TC-FPR 43 |
| Potent FPR2 agonist | |
| 4625 | TC OT 39 |
| Potent non-peptide oxytocin receptor partial agonist; also V1a receptor antagonist | |
| 4629 | GSK2578215A |
| Potent, selective LRRK2 inhibitor; brain penetrant | |
| 4630 | SB 747651A dihydrochloride |
| Potent MSK1 inhibitor; also inhibits other AGC group kinases | |
| 4632 | TC-I 2000 |
| TRPM8 blocker | |
| 4633 | Pam3CSK4 |
| TLR1/2 agonist; induces cytokine production | |
| 4635 | SC 79 |
| Akt activator | |
| 4637 | Pam2CSK4 |
| TLR2/6 agonist; induces TNF-α production | |
| 4641 | BI 6015 |
| Hepatocyte nuclear factor 4α (HNF4α) antagonist | |
| 4642 | 4-CMTB |
| FFA2 agonist; also exhibits positive allosteric modulatory activity | |
| 4643 | PCI 34051 |
| Potent and selective HDAC8 inhibitor | |
| 4645 | Z-VRPR-FMK trifluoroacetate salt |
| Irreversible MALT1 inhibitor | |
| 4646 | Elacridar hydrochloride |
| P-gp and BCRP inhibitor | |
| 4647 | GR 203040 |
| Potent and selective NK1 antagonist | |
| 4650 | I-BET 151 dihydrochloride |
| BET bromodomain inhibitor; also promotes differentiation of hiPSCs into megakaryocytes | |
| 4651 | JW 67 |
| Wnt pathway inhibitor; induces degradation of active β-catenin | |
| 4652 | SAHA |
| Class I and II HDAC inhibitor | |
| 4655 | NSC 74859 |
| Selective STAT3 inhibitor | |
| 4656 | (D)-(+)-Neopterin |
| Stimulated by IFN-γ; marker of immune activation | |
| 4657 | Zolmitriptan |
| Potent 5-HT1B/1D/1F agonist | |
| 4660 | KB SRC 4 |
| Potent and selective c-Src inhibitor | |
| 4663 | Apocynin |
| NADPH-oxidase inhibitor | |
| 4664 | Obtustatin |
| Potent and selective α1β1 inhibitor | |
| 4673 | SB 674042 |
| Potent and selective non-peptide OX1 antagonist | |
| 4676 | ARRY 520 trifluoroacetate |
| Potent and selective kinesin spindle protein (KSP) inhibitor; induces Mcl-1 degradation | |
| 4677 | CYM 50260 |
| Potent and selective S1P4 agonist | |
| 4678 | CYM 50308 |
| Potent and selective S1P4 agonist | |
| 4679 | CYM 50358 hydrochloride |
| Potent and selective S1P4 antagonist | |
| 4683 | RFRP 3 (human) |
| NPFF1 agonist; GnIH homolog | |
| 4685 | KL 001 |
| Cryptochrome protein stabilizer; lengthens circadian period | |
| 4686 | Xanthohumol |
| p97 ATPase (VCP) inhibitor | |
| 4687 | ML 252 |
| Potent and selective KV7.2 inhibitor; brain penetrant | |
| 4688 | GSK J2 |
| Inactive isomer of GSK J1 (Cat. No. 4593) | |
| 4690 | Fmk |
| Irreversible ribosomal S6 kinase 1/2 inhibitor | |
| 4691 | NAV 26 |
| Selective Nav1.7 channel blocker | |
| 4694 | Ro 5-3335 |
| Core binding factor inhibitor; attenuates hematopoiesis | |
| 4695 | Ischemin sodium salt |
| CBP inhibitor; cell permeable |